Dentsply Sirona Inc Stock Price, News & Analysis

Dentsply Sirona (Nasdaq: XRAY) announces its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2022, at 11:15 am ET. CEO Don Casey will present during this virtual event. Interested parties can access a live audio webcast and presentation materials on the Company’s investor website. A replay will be available for 30 days after the presentation. Dentsply Sirona is a leading manufacturer of dental products, providing innovative solutions to enhance patient care.

Dentsply Sirona (Nasdaq: XRAY) declared a quarterly cash dividend of $0.11 per share, with an indicated annual rate of $0.44. The dividend will be payable on January 14, 2022 to shareholders on record as of December 31, 2021. Dentsply Sirona, a leading manufacturer of dental products, has a rich history of 134 years in innovation and service, offering a wide range of solutions to advance patient care. The company is committed to delivering high-quality dental and oral health products.

Dentsply Sirona (Nasdaq: XRAY) announces an integration of its Primescan and Omnicam scanners with 3Shape’s lab software, enhancing workflows and patient outcomes. This collaboration allows dental practices using these scanners to securely share data with labs via the Connect Case Center. The integration aims to streamline communication and improve patient care, with features available to labs utilizing 3Shape’s upgraded Dental System software. Both companies focus on expanding technology access to benefit the dental community.

Dentsply Sirona (Nasdaq: XRAY) announced its participation in three upcoming investor conferences. The presentations will occur at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021, at 4:20 PM ET, followed by the Evercore ISI 4th Annual HealthConX Conference on December 1, 2021, at 1:00 PM ET, and the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 2, 2021. A webcast recording for the last event will be available on November 22, 2021, at 10:00 AM ET. Live webcasts can be accessed via the company's investor website.

Dentsply Sirona (Nasdaq: XRAY) reported a strong third-quarter performance with net sales reaching $1,069 million, a 19.4% increase from last year. GAAP EPS rose to $0.47 from $0.25 in 2020, while Non-GAAP EPS slightly increased to $0.68. The company also raised its FY2021 revenue outlook, expecting $4.25 billion to $4.3 billion, up 27-30% year-over-year. Notably, organic sales grew over 21%.

Dentsply Sirona announced an investor conference call scheduled for November 4, 2021, at 8:30 am ET to discuss its financial results. The presentation related to the call will be available on the investor section of the company’s website. Participants can join the call by dialing +1-877-370-7637 for domestic or +1-629-228-0723 for international calls. A replay will be accessible for one week post-call. Dentsply Sirona is the largest manufacturer of professional dental products and is listed on Nasdaq under the symbol XRAY.

Dentsply Sirona, the largest dental product manufacturer, announced a partnership with Smile Train, enhancing cleft care access globally. This five-year collaboration aims to provide free cleft surgeries and essential care for over 1.5 million children in more than 90 countries. Key initiatives include supporting global treatment standards, leveraging digital technologies, and offering training programs for local healthcare professionals. The partnership seeks to empower communities and ensure a lasting impact on cleft care.

Dentsply Sirona introduces a revamped Implants business, launching DS Implants that integrates brands like Simplant and MIS. The initiative presents three digital workflows designed to enhance implantology practices: Single Tooth, Partial Multiple Tooth Replacement, and Full Arch Signature Workflows, which aim to boost efficiency and patient satisfaction. A highlight is the DS PrimeTaper, a self-tapping implant with a tapered design for easier insertion and long-term bone stability. The company emphasizes a global clinical education program to support digital implant skills development among clinicians.